Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Other financing activities (2016 - 2017)

Rein Therapeutics (RNTX) has disclosed Other financing activities for 2 consecutive years, with $255000.0 as the latest value for Q4 2017.

  • Quarterly Other financing activities rose 54.55% to $255000.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $165000.0 through Dec 2017, changed N/A year-over-year, with the annual reading at $2.3 million for FY2017, 1180.0% up from the prior year.
  • Other financing activities for Q4 2017 was $255000.0 at Rein Therapeutics, down from $1.6 million in the prior quarter.
  • The five-year high for Other financing activities was $1.6 million in Q3 2017, with the low at -$1.9 million in Q2 2017.